Traditional Chinese medicine Shenqi Compound to improve lower extremity atherosclerosis of patients with type 2 diabetes by affecting blood glucose fluctuation: study protocol for a randomized controlled multicenter trial
Phase 1
Recruiting
- Conditions
- type 2 diabetes with lower extremity atherosclerosis
- Registration Number
- ITMCTR1900025355
- Lead Sponsor
- Teaching Hospital of Chengdu University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Those who voluntarily participate in the trial and sign the informed consent form;
2. Aged 35 to 65 years old;
3. In line with the diagnosis of Western medicine type 2 diabetes and TCM syndrome diagnosis and lower extremity atherosclerosis.
Exclusion Criteria
1. Patients with heart and kidney dysfunction, acute coronary syndrome, cerebrovascular accident, hematopoietic disorders and mental illness;
2. Patients with acute metabolic disorders such as diabetic ketoacidosis within the past 1 month;
3. Pregnant women, lactating women;
4. Severe infection in the past 1 month;
5. Patients with allergic constitution;
6. Uncooperative in run-in period;
7. Having a history of alcoholism or drug abuse.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method